

Can't find Airsupra at your pharmacy? Learn why this rescue inhaler is hard to find in 2026 and what you can do to get your prescription filled today.
If you've been prescribed Airsupra and your pharmacy says they don't have it in stock, you're not alone. Since its FDA approval in January 2023, many patients have struggled to find this first-of-its-kind rescue inhaler at their local pharmacy. With a list price of over $500 per inhaler and limited insurance coverage, pharmacies sometimes choose not to stock it — leaving patients frustrated and without their medication.
In this article, we'll explain what Airsupra is, why it's so hard to find, and what you can do right now to locate it near you.
Airsupra is the brand name for a combination inhaler containing Albuterol (a short-acting bronchodilator) and Budesonide (an inhaled corticosteroid). It's made by AstraZeneca and was the first FDA-approved rescue inhaler designed to both open your airways and reduce inflammation at the same time.
Traditional rescue inhalers like Ventolin HFA or ProAir HFA only contain Albuterol, which opens your airways but does nothing to address the inflammation that causes asthma attacks. Airsupra's dual-action approach helps treat symptoms in the moment while also reducing the risk of future asthma attacks.
Airsupra is approved for adults aged 18 and older with asthma. The typical dose is 2 inhalations as needed, with a maximum of 12 inhalations in a 24-hour period. For more about how it works, see our guide on how Airsupra works.
There are several reasons why you might be having trouble finding Airsupra at your local pharmacy. Unlike many other asthma medications, the challenges are less about a manufacturing shortage and more about cost, coverage, and pharmacy stocking decisions.
As of 2026, there is no generic version of Airsupra available. That means every inhaler sold is the brand-name product, priced at a list price of $503.93. When a medication has no generic alternative and carries a high price tag, pharmacies — especially chain pharmacies — may be less likely to keep it on their shelves. They simply don't want to tie up inventory in an expensive product that might not sell quickly.
While Airsupra is covered by most commercial insurance plans, coverage varies significantly. Some insurers require prior authorization, meaning your doctor has to explain why you need Airsupra specifically instead of a standard Albuterol inhaler. Other plans may require step therapy, which means you must try cheaper alternatives first before they'll cover Airsupra.
Medicare Part D plans vary widely — some cover it, others don't. If a pharmacy doesn't see consistent demand because insurance hurdles prevent patients from filling prescriptions, they may stop stocking it altogether.
Airsupra was only approved in January 2023 and launched later that year. In the world of pharmacy, that's still relatively new. Many pharmacists and physicians are still getting familiar with it. Some pharmacies haven't added it to their regular inventory because they haven't seen enough prescriptions come through yet.
Large chain pharmacies use algorithms to decide what to stock based on local demand. If your area doesn't have many Airsupra prescriptions being filled, the pharmacy's system may not flag it as a product worth stocking. Independent pharmacies may be more flexible, but they face their own challenges with the high cost of carrying brand-name inventory.
The good news is that Airsupra is not in a formal manufacturing shortage. It's being produced — the challenge is finding a pharmacy that has it. Here are some steps you can take:
The fastest way to find Airsupra in stock is to use Medfinder. Medfinder shows you which pharmacies near you currently have Airsupra available, so you don't have to call around. It's free and takes just a few seconds.
Independent pharmacies are often more willing to order specialty medications like Airsupra. They can typically get it within 1-2 business days through their wholesaler. Don't overlook smaller, local pharmacies — they may be your best bet. For more tips, check out our guide on how to find Airsupra in stock near you.
If your regular pharmacy doesn't have Airsupra, ask them to place a special order. Most pharmacies can order it from their distributor and have it within a day or two. Just make sure your prescription and any required prior authorization are already in place.
If cost is making it harder to fill your prescription, AstraZeneca offers the SUPRA Savings Card that can reduce your cost to as low as $0 for commercially insured patients. This can help pharmacies feel more confident stocking it when patients can actually afford to pick it up. Learn more in our article on how to save money on Airsupra.
If prior authorization is required by your insurance, make sure your prescriber submits it promptly. Some doctors' offices have staff dedicated to handling prior authorizations. You can also ask about alternatives to Airsupra if you need relief while waiting.
Airsupra is a genuinely innovative medication that represents a significant advance in asthma treatment. The fact that it's hard to find isn't because of a manufacturing problem — it's a combination of being new, expensive, and inconsistently covered by insurance. But with the right tools and a little persistence, you can find it.
Start by checking Medfinder to see which pharmacies near you have Airsupra in stock right now. And if you're struggling with cost, explore the manufacturer savings programs that could make it much more affordable.
For a full overview of the medication, see our guide on what Airsupra is and what you need to know.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.